Substance P, insulinlike growth factor 1, and surface healing

Arch Ophthalmol. 2002 Feb;120(2):215-7.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Brimonidine Tartrate
  • Corneal Diseases / drug therapy*
  • Corneal Diseases / etiology
  • Drug Therapy, Combination
  • Epithelium, Corneal / drug effects*
  • Epithelium, Corneal / pathology
  • Female
  • Humans
  • Insulin-Like Growth Factor I / administration & dosage
  • Insulin-Like Growth Factor I / therapeutic use*
  • Keratoplasty, Penetrating / adverse effects
  • Ophthalmic Solutions
  • Polymyxin B / therapeutic use
  • Quinoxalines / therapeutic use
  • Substance P / administration & dosage
  • Substance P / therapeutic use*
  • Wound Healing / drug effects*

Substances

  • Anti-Bacterial Agents
  • Antihypertensive Agents
  • Ophthalmic Solutions
  • Quinoxalines
  • Substance P
  • Brimonidine Tartrate
  • Insulin-Like Growth Factor I
  • Polymyxin B